Clinical trials in Europe
Dr. Birkmayer's institute in Austria has treated a number of Alzheimer's patients with moderate to severe symptoms. They take four 5mg NADH tablets a day, a total daily dosage of 20mg of NADH. Most Alzheimer's patients in the study realized increased physical and mental energy. No side effects have been observed in these patients even after 2 years of treatment. It is the successful treatment of these Alzheimer's patients that lead to further testing.

Clinical trials in the United States
A research study in the fight against Alzheimer's disease is currently underway. It is directed by Stanley Cohan, MD, Ph.D., and Professor and Chairman of the Department of Neurology, at Georgetown University Medical Center outside Washington, DC.

Dr. Stanley Cohan says, "NADH is a naturally-occurring compound (a coenzyme) with few side effects that has shown promise in Europe and in preliminary trials with Alzheimer’s disease patients."

Dr. Stanley Cohan goes on to say, "Currently, treatments and therapies for people with Alzheimer’s disease are inadequate. This research is a first step toward determining if this coenzyme NADH is of potential benefit to Alzheimer’s patients."

Georgetown University Medical Center is a world class research medical center, leading the way in new methods and treatments.

So, why wait until there studies are complete? The Alzheimer's disease patients has everything to gain and nothing to lose. Fight the advance of Alzheimer’s disease today.

The results of the Dr. Stanley Cohan's Georgetown University Medical Center study are due late 1998. The results will be posted here when the information becomes available.

NADH dosage
Dr. Birkmayer's institute in Austria, is treating a number of Alzheimer's patients with moderate to severe symptoms. They take four 5mg NADH tablets a day, a total daily dosage of 20mg of NADH.

Alzheimer's Clinical Study
Dr. Birkmayer's institute in Austria has treated a number of Alzheimer's patients with moderate to severe symptoms. They have all realized increased physical and mental energy. No side effects have been observed in these patients even after 2 years of treatment. It is the successful treatment of these Alzheimer's patients that lead to the further testing of NADH.

In a open label trial of Alzheimer's patients, NADH was used as the medication in the treatment of Alzheimer's disease. The patients received NADH by oral tablets. You can get the same NADH oral tablet here at this web site. The NADH oral tablet is called Enada®.

We have included the Alzheimer's disease clinical trial results in this web site. It is very difficult to read, and very technical in nature. The clinical trial study results are usually read by health care professionals. The section is for the people who want to bring the actual clinical research study to their doctor or health care professional

. . . Alzheimer's 3, continued on the next page